Abstract
Administration of IL-11 prevented lethal graft-versus-host disease (GVHD) in a murine bone marrow transplant (BMT) model (B6 --> B6D2F1) across MHC and minor H antigen barriers (survival at day 50: 90 vs 20%, P < 0.001). Surpisingly, IL-11 administration polarized the donor T cell cytokine responses to host antigen after BMT with a 50% reduction in IFNgamma and IL-2 secretion and a 10-fold increase in IL-4. This polarization of T cell responses was associated with reduced IFNgamma serum levels and decreased IL-12 production in mixed lymphocyte cultures (MLC). In addition, IL-11 prevented small bowel damage and reduced serum endotoxin levels by 80%. Treatment with IL-11 also reduced TNFalpha serum levels and suppressed TNFalpha secretion by macrophages to LPS stimulation in vitro. IL-11 thus decreased GVHD morbidity and mortality by three mechanisms: (a) polarization of donor T cells; (b) protection of the small bowel; and (c) suppression of inflammatory cytokines such as TNFalpha. We conclude that brief treatment with IL-11 may represent a novel strategy to prevent T cell-mediated inflammatory processes such as GVHD.
Full Text
The Full Text of this article is available as a PDF (461.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adams R. B., Planchon S. M., Roche J. K. IFN-gamma modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding. J Immunol. 1993 Mar 15;150(6):2356–2363. [PubMed] [Google Scholar]
- Antin J. H., Ferrara J. L. Cytokine dysregulation and acute graft-versus-host disease. Blood. 1992 Dec 15;80(12):2964–2968. [PubMed] [Google Scholar]
- Baker M. B., Altman N. H., Podack E. R., Levy R. B. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J Exp Med. 1996 Jun 1;183(6):2645–2656. doi: 10.1084/jem.183.6.2645. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bensinger W. I., Clift R., Martin P., Appelbaum F. R., Demirer T., Gooley T., Lilleby K., Rowley S., Sanders J., Storb R. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood. 1996 Oct 1;88(7):2794–2800. [PubMed] [Google Scholar]
- Blatter D. D., Crawford J. M., Ferrara J. L. Nuclear magnetic resonance of hepatic graft-versus-host disease in mice. Transplantation. 1990 Dec;50(6):1011–1018. doi: 10.1097/00007890-199012000-00023. [DOI] [PubMed] [Google Scholar]
- Briscoe D. M., Henault L. E., Geehan C., Alexander S. I., Lichtman A. H. Human endothelial cell costimulation of T cell IFN-gamma production. J Immunol. 1997 Oct 1;159(7):3247–3256. [PubMed] [Google Scholar]
- Chang M., Williams A., Ishizawa L., Knoppel A., van de Ven C., Cairo M. S. Endogenous interleukin-11 (IL-11) expression is increased and prophylactic use of exogenous IL-11 enhances platelet recovery and improves survival during thrombocytopenia associated with experimental group B streptococcal sepsis in neonatal rats. Blood Cells Mol Dis. 1996;22(1):57–67. doi: 10.1006/bcmd.1996.0009. [DOI] [PubMed] [Google Scholar]
- Cooke K. R., Kobzik L., Martin T. R., Brewer J., Delmonte J., Jr, Crawford J. M., Ferrara J. L. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood. 1996 Oct 15;88(8):3230–3239. [PubMed] [Google Scholar]
- Desreumaux P., Brandt E., Gambiez L., Emilie D., Geboes K., Klein O., Ectors N., Cortot A., Capron M., Colombel J. F. Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology. 1997 Jul;113(1):118–126. doi: 10.1016/s0016-5085(97)70116-1. [DOI] [PubMed] [Google Scholar]
- Du X. X., Doerschuk C. M., Orazi A., Williams D. A. A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood. 1994 Jan 1;83(1):33–37. [PubMed] [Google Scholar]
- Du X. X., Neben T., Goldman S., Williams D. A. Effects of recombinant human interleukin-11 on hematopoietic reconstitution in transplant mice: acceleration of recovery of peripheral blood neutrophils and platelets. Blood. 1993 Jan 1;81(1):27–34. [PubMed] [Google Scholar]
- Du X., Williams D. A. Interleukin-11: review of molecular, cell biology, and clinical use. Blood. 1997 Jun 1;89(11):3897–3908. [PubMed] [Google Scholar]
- Ferrara J. L., Deeg H. J. Graft-versus-host disease. N Engl J Med. 1991 Mar 7;324(10):667–674. doi: 10.1056/NEJM199103073241005. [DOI] [PubMed] [Google Scholar]
- Fowler D. H., Breglio J., Nagel G., Eckhaus M. A., Gress R. E. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease. J Immunol. 1996 Dec 1;157(11):4811–4821. [PubMed] [Google Scholar]
- Fowler D. H., Kurasawa K., Husebekk A., Cohen P. A., Gress R. E. Cells of Th2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction. Regulation of cytokines and CD8+ lymphoid engraftment. J Immunol. 1994 Feb 1;152(3):1004–1013. [PubMed] [Google Scholar]
- Fowler D. H., Kurasawa K., Smith R., Gress R. E. Donor lymphoid cells of Th2 cytokine phenotype reduce lethal graft versus host disease and facilitate fully allogeneic cell transfers in sublethally irradiated mice. Prog Clin Biol Res. 1994;389:533–540. [PubMed] [Google Scholar]
- Hakim F. T., Payne S., Shearer G. M. Recovery of T cell populations after acute graft-vs-host reaction. J Immunol. 1994 Jan 1;152(1):58–64. [PubMed] [Google Scholar]
- Hill G. R., Crawford J. M., Cooke K. R., Brinson Y. S., Pan L., Ferrara J. L. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood. 1997 Oct 15;90(8):3204–3213. [PubMed] [Google Scholar]
- Hill G. R., Krenger W., Ferrara J. L. The role of cytokines in acute graft-versus-host disease. Cytokines Cell Mol Ther. 1997 Dec;3(4):257–266. [PubMed] [Google Scholar]
- Keith J. C., Jr, Albert L., Sonis S. T., Pfeiffer C. J., Schaub R. G. IL-11, a pleiotropic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology. Stem Cells. 1994;12 (Suppl 1):79–90. [PubMed] [Google Scholar]
- Kichian K., Nestel F. P., Kim D., Ponka P., Lapp W. S. IL-12 p40 messenger RNA expression in target organs during acute graft-versus-host disease. Possible involvement of IFN-gamma. J Immunol. 1996 Oct 1;157(7):2851–2856. [PubMed] [Google Scholar]
- Krenger W., Cooke K. R., Crawford J. M., Sonis S. T., Simmons R., Pan L., Delmonte J., Jr, Karandikar M., Ferrara J. L. Transplantation of polarized type 2 donor T cells reduces mortality caused by experimental graft-versus-host disease. Transplantation. 1996 Nov 15;62(9):1278–1285. doi: 10.1097/00007890-199611150-00018. [DOI] [PubMed] [Google Scholar]
- Krenger W., Hill G. R., Ferrara J. L. Cytokine cascades in acute graft-versus-host disease. Transplantation. 1997 Aug 27;64(4):553–558. doi: 10.1097/00007890-199708270-00001. [DOI] [PubMed] [Google Scholar]
- Krenger W., Snyder K. M., Byon J. C., Falzarano G., Ferrara J. L. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease. J Immunol. 1995 Jul 15;155(2):585–593. [PubMed] [Google Scholar]
- Liu Q., Du X. X., Schindel D. T., Yang Z. X., Rescorla F. J., Williams D. A., Grosfeld J. L. Trophic effects of interleukin-11 in rats with experimental short bowel syndrome. J Pediatr Surg. 1996 Aug;31(8):1047–1051. doi: 10.1016/s0022-3468(96)90084-6. [DOI] [PubMed] [Google Scholar]
- Madara J. L., Stafford J. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest. 1989 Feb;83(2):724–727. doi: 10.1172/JCI113938. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maze R., Moritz T., Williams D. A. Increased survival and multilineage hematopoietic protection from delayed and severe myelosuppressive effects of a nitrosourea with recombinant interleukin-11. Cancer Res. 1994 Sep 15;54(18):4947–4951. [PubMed] [Google Scholar]
- Morse H. C., 3rd, Shen F. W., Hämmerling U. Genetic nomenclature for loci controlling mouse lymphocyte antigens. Immunogenetics. 1987;25(2):71–78. doi: 10.1007/BF00364270. [DOI] [PubMed] [Google Scholar]
- Mowat A. M. Antibodies to IFN-gamma prevent immunologically mediated intestinal damage in murine graft-versus-host reaction. Immunology. 1989 Sep;68(1):18–23. [PMC free article] [PubMed] [Google Scholar]
- Nestel F. P., Price K. S., Seemayer T. A., Lapp W. S. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease. J Exp Med. 1992 Feb 1;175(2):405–413. doi: 10.1084/jem.175.2.405. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nicholson L. B., Kuchroo V. K. Manipulation of the Th1/Th2 balance in autoimmune disease. Curr Opin Immunol. 1996 Dec;8(6):837–842. doi: 10.1016/s0952-7915(96)80013-6. [DOI] [PubMed] [Google Scholar]
- Niessner M., Volk B. A. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol. 1995 Sep;101(3):428–435. doi: 10.1111/j.1365-2249.1995.tb03130.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Orazi A., Du X., Yang Z., Kashai M., Williams D. A. Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab Invest. 1996 Jul;75(1):33–42. [PubMed] [Google Scholar]
- Pan L., Delmonte J., Jr, Jalonen C. K., Ferrara J. L. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood. 1995 Dec 15;86(12):4422–4429. [PubMed] [Google Scholar]
- Paul S. R., Barut B. A., Bennett F., Cochran M. A., Anderson K. C. Lack of a role of interleukin 11 in the growth of multiple myeloma. Leuk Res. 1992;16(3):247–252. doi: 10.1016/0145-2126(92)90062-c. [DOI] [PubMed] [Google Scholar]
- Peterson R. L., Bozza M. M., Dorner A. J. Interleukin-11 induces intestinal epithelial cell growth arrest through effects on retinoblastoma protein phosphorylation. Am J Pathol. 1996 Sep;149(3):895–902. [PMC free article] [PubMed] [Google Scholar]
- Pfeiffer C. J., Sato S., Qiu B. S., Keith J. C., Evangelista S. Cellular pathology of experimental colitis induced by trinitrobenzenesulphonic acid (TNBS): protective effects of recombinant human interleukin-11. Inflammopharmacology. 1997;5(4):363–381. doi: 10.1007/s10787-997-0033-6. [DOI] [PubMed] [Google Scholar]
- Piguet P. F., Grau G. E., Allet B., Vassalli P. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease. J Exp Med. 1987 Nov 1;166(5):1280–1289. doi: 10.1084/jem.166.5.1280. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Potten C. S. Protection of the small intestinal clonogenic stem cells from radiation-induced damage by pretreatment with interleukin 11 also increases murine survival time. Stem Cells. 1996 Jul;14(4):452–459. doi: 10.1002/stem.140452. [DOI] [PubMed] [Google Scholar]
- Qiu B. S., Pfeiffer C. J., Keith J. C., Jr Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats. Dig Dis Sci. 1996 Aug;41(8):1625–1630. doi: 10.1007/BF02087911. [DOI] [PubMed] [Google Scholar]
- Redlich C. A., Gao X., Rockwell S., Kelley M., Elias J. A. IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. J Immunol. 1996 Aug 15;157(4):1705–1710. [PubMed] [Google Scholar]
- Rus V., Svetic A., Nguyen P., Gause W. C., Via C. S. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells. J Immunol. 1995 Sep 1;155(5):2396–2406. [PubMed] [Google Scholar]
- Schmitz N., Dreger P., Suttorp M., Rohwedder E. B., Haferlach T., Löffler H., Hunter A., Russell N. H. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) Blood. 1995 Mar 15;85(6):1666–1672. [PubMed] [Google Scholar]
- Snover D. C., Weisdorf S. A., Ramsay N. K., McGlave P., Kersey J. H. Hepatic graft versus host disease: a study of the predictive value of liver biopsy in diagnosis. Hepatology. 1984 Jan-Feb;4(1):123–130. doi: 10.1002/hep.1840040122. [DOI] [PubMed] [Google Scholar]
- Snover D. C., Weisdorf S. A., Vercellotti G. M., Rank B., Hutton S., McGlave P. A histopathologic study of gastric and small intestinal graft-versus-host disease following allogeneic bone marrow transplantation. Hum Pathol. 1985 Apr;16(4):387–392. doi: 10.1016/s0046-8177(85)80232-x. [DOI] [PubMed] [Google Scholar]
- Sonis S., Muska A., O'Brien J., Van Vugt A., Langer-Safer P., Keith J. Alteration in the frequency, severity and duration of chemotherapy-induced mucositis in hamsters by interleukin-11. Eur J Cancer B Oral Oncol. 1995 Jul;31B(4):261–266. doi: 10.1016/0964-1955(95)00015-a. [DOI] [PubMed] [Google Scholar]
- Storek J., Gooley T., Siadak M., Bensinger W. I., Maloney D. G., Chauncey T. R., Flowers M., Sullivan K. M., Witherspoon R. P., Rowley S. D. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood. 1997 Dec 15;90(12):4705–4709. [PubMed] [Google Scholar]
- Storek J., Saxon A. Reconstitution of B cell immunity following bone marrow transplantation. Bone Marrow Transplant. 1992 Jun;9(6):395–408. [PubMed] [Google Scholar]
- Strom T. B., Roy-Chaudhury P., Manfro R., Zheng X. X., Nickerson P. W., Wood K., Bushell A. The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol. 1996 Oct;8(5):688–693. doi: 10.1016/s0952-7915(96)80087-2. [DOI] [PubMed] [Google Scholar]
- Sykes M., Abraham V. S., Harty M. W., Pearson D. A. IL-2 reduces graft-versus-host disease and preserves a graft-versus-leukemia effect by selectively inhibiting CD4+ T cell activity. J Immunol. 1993 Jan 1;150(1):197–205. [PubMed] [Google Scholar]
- Sykes M., Szot G. L., Nguyen P. L., Pearson D. A. Interleukin-12 inhibits murine graft-versus-host disease. Blood. 1995 Sep 15;86(6):2429–2438. [PubMed] [Google Scholar]
- Szebeni J., Wang M. G., Pearson D. A., Szot G. L., Sykes M. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease. Transplantation. 1994 Dec 27;58(12):1385–1393. [PubMed] [Google Scholar]
- Teicher B. A., Chen Y. N., Ara G., Emi Y., Kakeji Y., Maehara Y., Keyes S., Northey D. Interaction of interleukin-11 with cytotoxic therapies in vitro against CEM cells and in vivo against EMT-6 murine mammary carcinoma. Int J Cancer. 1996 Sep 17;67(6):864–870. doi: 10.1002/(SICI)1097-0215(19960917)67:6<864::AID-IJC17>3.0.CO;2-1. [DOI] [PubMed] [Google Scholar]
- Trepicchio W. L., Bozza M., Pedneault G., Dorner A. J. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J Immunol. 1996 Oct 15;157(8):3627–3634. [PubMed] [Google Scholar]
- Trepicchio W. L., Wang L., Bozza M., Dorner A. J. IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappaB. J Immunol. 1997 Dec 1;159(11):5661–5670. [PubMed] [Google Scholar]
- Via C. S., Sharrow S. O., Shearer G. M. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. J Immunol. 1987 Sep 15;139(6):1840–1849. [PubMed] [Google Scholar]
- Williamson E., Garside P., Bradley J. A., More I. A., Mowat A. M. Neutralizing IL-12 during induction of murine acute graft-versus-host disease polarizes the cytokine profile toward a Th2-type alloimmune response and confers long term protection from disease. J Immunol. 1997 Aug 1;159(3):1208–1215. [PubMed] [Google Scholar]
- Yang Y. G., Sergio J. J., Pearson D. A., Szot G. L., Shimizu A., Sykes M. Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice. Blood. 1997 Dec 1;90(11):4651–4660. [PubMed] [Google Scholar]